17.08.2018 Views

Sample Global Pharmaceutical Retail Market Final

Globally, the market for Pharmaceutical Retail has been growing at a swift pace on the back of rising healthcare expenditure, increasing cognizance about various respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), paradigm shift of consumers towards organized players which offer high quality drugs and medicines etc. According to Azoth Analytics research report “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) -- By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” the global market is projected to display a robust growth represented by a CAGR of 4.94% during 2018 – 2023. Standalone/Independent segment has witnessed growth at a noteworthy rate over the past few years. However, Organized retail pharmacy chains is expected to witness robust growth in the forecast period due to convenient services offered which includes same-day home delivery; patient charge accounts; immunizations; compounding; and durable medical goods, maintaining health record of patient, e-prescribing in the developed nations etc. Amongst the regions, North America accounts for the largest regional share in the global Pharmaceutical Retail market in 2017. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-pharmaceutical-retail-market-analysis-by-type-independent-retailers-pharmacy-chain-market-share-by-region-by-country-opportunities-and-forecasts-2018-2023-r21188 Visit us: http://azothanalytics.com/research/healthcare-pharma-c1

Globally, the market for Pharmaceutical Retail has been growing at a swift pace on the back of rising healthcare expenditure, increasing cognizance about various respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), paradigm shift of consumers towards organized players which offer high quality drugs and medicines etc.

According to Azoth Analytics research report “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) -- By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” the global market is projected to display a robust growth represented by a CAGR of 4.94% during 2018 – 2023.

Standalone/Independent segment has witnessed growth at a noteworthy rate over the past few years. However, Organized retail pharmacy chains is expected to witness robust growth in the forecast period due to convenient services offered which includes same-day home delivery; patient charge accounts; immunizations; compounding; and durable medical goods, maintaining health record of patient, e-prescribing in the developed nations etc. Amongst the regions, North America accounts for the largest regional share in the global Pharmaceutical Retail market in 2017.
Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-pharmaceutical-retail-market-analysis-by-type-independent-retailers-pharmacy-chain-market-share-by-region-by-country-opportunities-and-forecasts-2018-2023-r21188
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> – Analysis By Type (Independent<br />

<strong>Retail</strong>ers, Pharmacy Chain), <strong>Market</strong> Share, By Region, By Country:<br />

Opportunities and Forecasts (2018-2023)<br />

• <strong>Market</strong> Share of Companies – By Country<br />

• By Region - North America, Europe, Asia<br />

Pacific, ROW.<br />

• By Country – United States, Canada, United<br />

Kingdom, Germany, India, China, Japan.<br />

July 2018


<strong>Global</strong><br />

Regional<br />

Country<br />

Scope of the Report – <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Historical<br />

Forecast<br />

<strong>Market</strong><br />

(By Value)<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

By Type,<br />

By Value<br />

Independent<br />

Chain<br />

By Segment,<br />

By Value<br />

<strong>Market</strong><br />

(By Value)<br />

By Type,<br />

By Value<br />

Prescription<br />

drugs<br />

Over the<br />

counter<br />

Independent<br />

Chain<br />

By Segment<br />

,By Value<br />

<strong>Market</strong><br />

(By Value)<br />

By Type,<br />

By Value<br />

By Segment,<br />

By Value<br />

Prescription<br />

drugs<br />

Over the<br />

counter<br />

Independent<br />

Chain<br />

Prescription<br />

drugs<br />

Over the<br />

counter<br />

Company Analysis<br />

Regional Analysis<br />

Country Analysis<br />

Walgreen Co, CVS Health, and Rite Aid, Jean Coutu, Shoppers Drug Mart, Nepstar , AS Watson, Matsumoto Kiyoshi,<br />

Anton Schlecker, Dirk Rossmann, Walgreen-owned Boots the Chemists<br />

North America, Europe, APAC, ROW<br />

US, Canda, Mexico, UK, Germany, France, China, India, Japan, Australia<br />

2


Table of Content<br />

S.No Particulars Page No.<br />

1. Research Methodology 19<br />

2. Executive Summary 20<br />

3. Strategic Recommendation 22<br />

3.1 More <strong>Market</strong> friendly regulations should be introduced across the globe 23<br />

3.2 APAC region to witness augmented growth in the forecast period. 24<br />

4. <strong>Pharmaceutical</strong> <strong>Retail</strong> Outlook 25<br />

5. <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Growth and Forecast 31<br />

5.1 By Value (2013-2017) 32<br />

5.2 By Value (2018-2023) 33<br />

6. <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Segmental Analysis 45<br />

3


Table of Content<br />

S.No Particulars Page No.<br />

6.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Distribution Channel: Breakdown (%) 46<br />

6.1.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Distribution Channel, 2017 (%) 47<br />

6.1.2 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Distribution Channel, 2023 (%) 48<br />

6.2 <strong>Global</strong> <strong>Pharmaceutical</strong> Online <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 51<br />

6.3 <strong>Global</strong> <strong>Pharmaceutical</strong> offline <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 54<br />

6.4 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type: Breakdown (%) 55<br />

6.4.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type, 2017 (%) 55<br />

6.4.2 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type, 2023 (%) 56<br />

6.5 <strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 57<br />

6.6 <strong>Global</strong> Organised Chain <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 58<br />

6.7 <strong>Global</strong> Others <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 59<br />

4


Table of Content<br />

S.No Particulars Page No.<br />

7. <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Regional Analysis 60<br />

7.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Region : Breakdown (%) 61<br />

7.1.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Region, 2017 (%) 61<br />

7.1.2 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Region, 2023 (%) 62<br />

7.2 North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Growth and Forecast 63<br />

7.2.1 By Value (2013-2017) 64<br />

7.2.2 By Value (2018-2023) 65<br />

7.3 North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type 72<br />

7.3.1 By Value (2013-2017) 73<br />

7.3.2 By Value (2018-2023) 74<br />

7.4 North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Country Analysis (U.S and Canada) 75<br />

7.4.1 U.S <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 77<br />

7.4.2 U.S <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 91<br />

7.4.3 Canada <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 96<br />

5


Table of Content<br />

S.No Particulars Page No.<br />

7.4.4 Canada <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 103<br />

7.5 Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Growth and Forecast 106<br />

7.5.1 By Value (2013-2017) 107<br />

7.5.2 By Value (2018-2023) 108<br />

7.6 Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type 117<br />

7.6.1 By Type, By Value (2013-2023) 118<br />

7.6.2 By Type, By Value (2013-2023) 119<br />

7.7 Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Country Analysis (U.K and Germany) 122<br />

7.7.1 U.K <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 123<br />

7.7.2 U.K <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 130<br />

6


Table of Content<br />

S.No Particulars Page No.<br />

7.7.3 Germany <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 135<br />

7.7.4 Germany <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 143<br />

7.8 APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Growth and Forecast 146<br />

7.8.1 By Value (2013-2017) 147<br />

7.8.2 By Value (2018-2023) 148<br />

7.9 APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Type<br />

7.9.1 By Type, By Value (2013-2027) 155<br />

7.9.2 By Type, By Value (2018-2023) 156<br />

7.10 APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Country Analysis (India, China and Japan) 157<br />

7.10.1 India <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 159<br />

7.10.2 India <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 169<br />

7.10.3 China <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 171<br />

7.10.4 China <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 181<br />

7


Table of Content<br />

S.No Particulars Page No.<br />

7.10.5 Japan <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value (2013-2023) 183<br />

7.10.6 Japan <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type, By Value (2013-2023) 186<br />

7.11 ROW <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: Growth and Forecast 187<br />

7.11.1 By Value (2013-2023) 188<br />

7.11.2 By Type, By Value (2013-2017) 191<br />

7.11.3 By Type, By Value (2018-2023) 132<br />

8. <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Dynamics 193<br />

8.1 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Drivers 194<br />

8.2 <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Restraints 200<br />

9. <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Trends 201<br />

10. Porter Five Force Analysis 205<br />

11. SWOT Analysis 207<br />

12. Company Profiling 209<br />

12.1 CVS Health 210<br />

8


Table of Content<br />

S.No Particulars Page No.<br />

12.2 Walgreens Boots Alliance Inc. 212<br />

12.3 Albertsons 215<br />

12.4 Rossmann 216<br />

12.5 Rite Aid 217<br />

12.6 Jean Coutu 218<br />

12.7 Nepstar 219<br />

13. About Us 220<br />

9


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 1: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion) 32<br />

Figure 2: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023 (USD Billion) 33<br />

Figure 3:<br />

Average price mark up of medicines in emerging markets at each stage of supply chain Post manufacturing<br />

range from 10%-75%<br />

Figure 4: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F 38<br />

Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total) 39<br />

Figure 6: Projected global population aged 60 years & above (In Billions) 39<br />

Figure 7: Projected global population (In Billions) 39<br />

Figure 8: World Life expectancy at birth for selected periods 40<br />

Figure 9: Life expectancy at birth for selected periods, By Region 40<br />

Figure 10: Projected medicine spending distribution, By Regions 2020 41<br />

Figure 11: Obese Population, By Country, 2017 (In Millions) 41<br />

Figure 12: <strong>Global</strong> Diabetic Adult Population, 2017 & 2045 (In %) 41<br />

Figure 13: Healthcare Expenditure (Share of GDP), By Select Country, 2012-2016 (In %) 42<br />

Figure 14: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Product Type, 2017 (%) 47<br />

Figure 15: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Product Type, 2023 (%) 48<br />

Figure 16: <strong>Global</strong> Online <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value, 2013-2017 (USD Billion) 51<br />

Figure 17: <strong>Global</strong> Online <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value, Forecast, 2018-2023(USD Billion) 51<br />

Figure 18: <strong>Global</strong> Offline <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> , By Value, 2013-2017 (USD Billion) 54<br />

Figure 19: <strong>Global</strong> Offline <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value, Forecast, 2018-2023(USD Billion) 54<br />

Figure 20: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Package Type, 2017 (%) 55<br />

34<br />

10


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 21: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Package Type, 2023 (%) 56<br />

Figure 22: <strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> , By Value, 2013-2017 (USD Billion) 57<br />

Figure 23: <strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>,By Value, Forecast, 2018-2023(USD Billion) 57<br />

Figure 24: <strong>Global</strong> Organized Chain <strong>Pharmaceutical</strong> <strong>Market</strong>, By Value, 2013-2017 (USD Billion) 58<br />

Figure 25: <strong>Global</strong> Organized Chain <strong>Pharmaceutical</strong> <strong>Market</strong>, By Value, Forecast, 2018-2023(USD Billion) 58<br />

Figure 26: <strong>Global</strong> Others <strong>Pharmaceutical</strong> <strong>Market</strong>, By Value, 2013-2017 (USD Billion) 59<br />

Figure 27: <strong>Global</strong> Others <strong>Pharmaceutical</strong> <strong>Market</strong>, By Value, Forecast, 2018-2023(USD Billion) 59<br />

Figure 28: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Region, 2017 (%) 61<br />

Figure 29: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Region, 2023 (%) 62<br />

Figure 30: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion) 64<br />

Figure 31: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023 (USD Billion) 65<br />

Figure 32: North America Healthcare Cost Per Capita, 2016 (USD) 66<br />

Figure 33: North America Population Ages 65 and above, 2012-2016 (% of Total) 66<br />

Figure 34: North America GDP, 2012-2016 (USD Trillion) 67<br />

Figure 35: North America GDP per capita, current prices, 2013-2023F (In USD) 67<br />

Figure 36: North America DALYs of Ischemic Heart Disease (2013-2016, %) 68<br />

Figure 37: North America DALYs of Chronic Kidney Disease (2013-2016, %) 68<br />

Figure 38: North America DALYs of COPD (2013-2016 %) 68<br />

Figure 39: North America DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 68<br />

Figure 40: North America DALYs of Diabetes (2013-2016, %) 68<br />

11


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 41: Savings from Generics in U.S Healthcare System, 2012-2016 (USD Billion) 69<br />

Figure 42: Savings from U.S Healthcare System, By Leading Diseases, 2016 (USD Billion) 70<br />

Figure 43: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2013-2023 (USD Billion) 73<br />

Figure 44: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2018-2023 (USD Billion) 74<br />

Figure 45: U.S. <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 77<br />

Figure 46: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD) 79<br />

Figure 47: United States, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Revenues 2016) 81<br />

Figure 48: Share of Leading companies in Metro areas 81<br />

Figure 49: Projected US Population over age 85 (in millions) 82<br />

Figure 50: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD) 84<br />

Figure 51: Pharmacy Industry Prescription Revenues (USD Billions) 84<br />

Figure 52: U.S., Prescription Drugs <strong>Market</strong> share, By Pharmacies 2017 85<br />

Figure 53: U.S., Population ages 65 and above, 2013-2016 (% of total) 85<br />

Figure 54: U.S., Population ages 65 and above, Forecast (In Millions) 85<br />

Figure 55: United States DALYs of Ischemic Heart Disease (2013-2016, %) 86<br />

Figure 56: United States DALYs of Chronic Kidney Disease (2013-2016, %) 86<br />

Figure 57: United States DALYs of COPD (2013-2016, %) 86<br />

Figure 58: United States DALYs of Alzheimer Disease and Other Dementias (2013-2016 %) 86<br />

Figure 59: United States DALYs of Diabetes Mellitus (2013-2016 %) 86<br />

Figure 60: Utilization of E-Prescribing, 2013-2017 ( in Billions ) 87<br />

12


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 61: United States, Nominal Spending on Medicines, 2013-2016 (USD Billions) 88<br />

Figure 62: United States, Medicine Invoice and Net Spending, 2013-2017(USD Billion) 89<br />

Figure 63: United States, Real Net Per Capita Medicine Spending and Growth, 2013-2017 (USD) 89<br />

Figure 64: U.S <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2013-2023 (USD Billion) 91<br />

Figure 65: Independent Pharmacy, By Social Media 93<br />

Figure 66: Canada <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 96<br />

Figure 67: Canada, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of outlets in 2017) 98<br />

Figure 68: Canada, Growth of retail prescriptions, 2013-2017 (%) 99<br />

Figure 69: Leading Store chains in Canada, 2016 99<br />

Figure 70: Canada, Expenditure on Health as a share of GDP, 2012-2016 (in %) 100<br />

Figure 71: Canada, Per Capita Healthcare Expenditure, 2012-2016 (USD) 100<br />

Figure 72: Canada, Population ages 65 and above, 2012-2016 (% of total) 100<br />

Figure 73: Canada DALYs of Ischemic Heart Disease (2013-2016 %) 101<br />

Figure 74: Canada DALYs of Chronic Kidney Disease (2013-2016, %) 101<br />

Figure 75: Canada DALYs of COPD (2013-2016, %) 101<br />

Figure 76: Canada DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 101<br />

Figure 77: Canada DALYs of Diabetes (2013-2016, %) 101<br />

Figure 78: Canada <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 103<br />

Figure 79: Canada <strong>Retail</strong> Pharmacies, By Outlet Type 2013-2017 104<br />

Figure 80: Major Players in <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> in North America 105<br />

13


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 81: Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion) 107<br />

Figure 82: Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023 (USD Billion) 108<br />

Figure 83: % of Pharmacies in Virtual <strong>Retail</strong> Chains Pharmacy in Europe, by countries 111<br />

Figure 84: Per Capita Health Expenditure, By Select Country, 2016 (USD) 112<br />

Figure 85: European Union, Population ages 65 and above, 2013-2017 (% of total) 112<br />

Figure 86: European Country Population Aged 65 and Above, 2012-2016 (% of Total) 113<br />

Figure 87: Share of Generics in <strong>Pharmaceutical</strong> <strong>Market</strong> Sales, By Volume (Ex-Factory Prices) 113<br />

Figure 88: Western Europe DALYs of Ischemic Heart Disease (2013-2016, %) 114<br />

Figure 89: Western Europe DALYs of Chronic Kidney Disease (2013-2016, %) 114<br />

Figure 90: Western Europe DALYs of COPD (2013-2016, %) 114<br />

Figure 91: Western Europe DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 114<br />

Figure 92: Western Europe DALYs of Diabetes (2013-2016 %) 114<br />

Figure 93: Breakdown of Total Health Expenditure in Europe (%) 115<br />

Figure 94: Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2017 (USD Billion) 118<br />

Figure 95: Europe <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2018-2023 (USD Billion) 119<br />

Figure 96: Number of Pharmacies in Europe 2016 120<br />

Figure 97: U.K <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 123<br />

Figure 98: United Kingdom, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of <strong>Retail</strong> Outlets 2017) 125<br />

Figure 99: United Kingdom <strong>Pharmaceutical</strong> Consumption, Daily Dosage per 1000 inhabitants per day 128<br />

Figure 100: U.K. <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 130<br />

14


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 101: United Kingdom, Number of Community Pharmacies 131<br />

Figure 102: United Kingdom, Number of Internet Pharmacies, 2013-2016 131<br />

Figure 103: U.K, Per Capita Health Expenditure, 2013-2017 (USD) 132<br />

Figure 104: U.K, Health Expenditure, Share of GDP, 2013-2017 (In %) 132<br />

Figure 105: United Kingdom DALYs of Ischemic Heart Disease (2013-2016, %) 133<br />

Figure 106: United Kingdom DALYs of Chronic Kidney Disease (2013-2016, %) 133<br />

Figure 107: United Kingdom DALYs of COPD (2013-2016 %) 133<br />

Figure 108: United Kingdom DALYs of Alzheimer Disease and Other Dementias (2013-2016 %) 133<br />

Figure 109: United Kingdom DALYs of Diabetes (2013-2016, %) 133<br />

Figure 110: Germany <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 135<br />

Figure 111: Germany, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of outlets in 2017) 137<br />

Figure 112: Germany, Type of pharmacies 138<br />

Figure 113: Germany, Population ages 65 and above, 2012-2016 (% total) 138<br />

Figure 114: Germany, Per Capita Health Expenditure, 2013-2017 (USD 139<br />

Figure 115: Germany, Health Expenditure, Share of GDP, 2013-2017 (In %) 139<br />

Figure 116: Germany DALYs of Ischemic Heart Disease (2013-2016, %) 140<br />

Figure 117: Germany DALYs of Chronic Kidney Disease (2013-2016, %) 140<br />

Figure 118: Germany DALYs of COPD (2013-2016,%) 140<br />

Figure 119: Germany DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 140<br />

Figure 120: Germany DALYs of Diabetes (2013-2016, %) 140<br />

15


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 121: Germany, Yearly vale of exported pharmaceuticals, 2012-2016 (In Billion Euro) 141<br />

Figure 122: Germany, Population ages 65 and above, 2012-2016 (% total) 141<br />

Figure 123: Germany <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 143<br />

Figure 124: Germany, Number of Individual Pharmacies 2014-2016 144<br />

Figure 125: Germany, Number of Branch Pharmacies, 2014-2016 144<br />

Figure 126: APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion) 147<br />

Figure 127: APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023(USD Billion) 148<br />

Figure 128: Population ages 65 and above, APAC Region, By Select Countries, 2016 (% of total) 151<br />

Figure 129: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total) 151<br />

Figure 130: South East Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2013-2016, %) 152<br />

Figure 131: South East Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2013-2016, %) 152<br />

Figure 132: South East Asia, East Asia, Oceania DALYs of COPD (2013-2016, %) 152<br />

Figure 133: South East Asia, Oceania, DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 152<br />

Figure 134: South East Asia, East Asia, Oceania DALYs of Diabetes (2013-2016, %) 152<br />

Figure 135: APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2017 (USD Billion) 155<br />

Figure 136: APAC <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2018-2023 (USD Billion) 156<br />

Figure 137: India <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 159<br />

Figure 138: India DALYs of Ischemic Heart Disease (2013-2016, %) 161<br />

Figure 139: India DALYs of Chronic Kidney Disease (2013-2016, %) 161<br />

Figure 140: India DALYs of COPD (2013-2016, %) 161<br />

16


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 141: India DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 161<br />

Figure 142: India DALYs of Diabetes (2013-2016 %) 161<br />

Figure 143: India, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of Outlets in 2017) 162<br />

Figure 144: India <strong>Pharmaceutical</strong> <strong>Retail</strong> 162<br />

Figure 145: India Revenue share of Indian <strong>Pharmaceutical</strong> sub segments 2015 (%) 163<br />

Figure 146: Indian <strong>Pharmaceutical</strong> Revenues (USD Billion) 164<br />

Figure 147: Supply chain of medicines in India 165<br />

Figure 148: Frequency of buying medicines in India , By Age 166<br />

Figure 149: Sources to buy Medicines in India, By Age 167<br />

Figure 150: India, Total Population, 2012-2022F (In Billion) 167<br />

Figure 151: India <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 169<br />

Figure 152: China <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 171<br />

Figure 153: China, <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of outlets in 2017) 173<br />

Figure 154: Number of pharmacists in China, 2016 176<br />

Figure 155: China, Population ages 65 and above, 2012-2016 (% of total) 177<br />

Figure 156: China Healthcare Expenditure Outlook (%) 177<br />

Figure 157: China, GDP Growth Per Year, 2015-2019 (In %) 178<br />

Figure 158: China, Total Population, 2012-2022F (In Billion) 178<br />

Figure 159: China DALYs of Ischemic Heart Disease (2013-2016, %) 179<br />

Figure 160: China DALYs of Chronic Kidney Disease (2013-2016, %) 179<br />

Figure 161: China DALYs of COPD (2013-2016, %) 179<br />

Figure 162: China DALYs of Alzheimer Disease and Other Dementias (2013-2016, %) 179<br />

17


List of Figures<br />

Figure No. Figure Title Page No.<br />

Figure 163: China DALYs of Diabetes (2013-2016, %) 179<br />

Figure 164: China <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 181<br />

Figure 165: Japan <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 183<br />

Figure 166: Japan <strong>Market</strong> Share of Leading Organized Pharmacy Chains (Number of outlets in 2017) 184<br />

Figure 167: Japan <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2023 (USD Billion) 186<br />

Figure 168: ROW <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion) 188<br />

Figure 169: ROW <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2013-2017 (USD Billion) 191<br />

Figure 170: ROW <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Type, By Value, 2018-2023 (USD Billion) 192<br />

Figure 171: CVS Health Corporation, Sales Revenue, 2013-2017 (USD Billion) 211<br />

Figure 172: CVS Health Corporation, Number of stores that operates a pharmacy , 2013-2017 211<br />

Figure 173: Walgreens <strong>Retail</strong> Pharmacy International Sales Revenue, 2015-2017 (USD Billion) 213<br />

Figure 174: Walgreens <strong>Retail</strong> Pharmacy US, Sales, By Business Sector, 2017 (%) 213<br />

Figure 175: <strong>Retail</strong> Pharmacy USA, By states 2017 214<br />

Figure 176: <strong>Retail</strong> Pharmacy International, By states 2017 214<br />

Table No. Table Title Page No.<br />

Table 1: List of Abbreviations 21<br />

Table 2: Recent Company Acquisitions in <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> 44<br />

Table 3: U.S., Number of <strong>Retail</strong> Stores, By Companies 2016 92<br />

Table 4: U.S., Total Pharmacies By Type 2013-2015 93<br />

Table 5: U.S., Availability of Pharmacies 2015 94<br />

Table 6: Advances Services by Community Pharmacies 126<br />

Table 7: Germany, Number of Community Pharmacies, By State 2016 145<br />

18


Research Methodology<br />

For our study on <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, we have conducted comprehensive secondary<br />

research followed by an extensive primary research. In the process of secondary research, we have<br />

scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg,<br />

Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we<br />

have interviewed various industry experts across the value chain of the Premium Oils.<br />

<strong>Market</strong> size of the actual period (2013-2017) has been evaluated on the basis of growth trends of<br />

the industry in the last five years, and confirming the findings through primary research. Annual<br />

reports of the companies were scanned to further validate the market size and to estimate the size<br />

of various other end-user sectors. <strong>Market</strong> sizing and growth in the forecast period (2018-2023) is<br />

estimated through product mapping, application in end-user industries, growth of allied sectors and<br />

historical growth pattern of the industry. All the relevant data points/ statistics in the forecast<br />

period are validated through relevant and reliable primary sources.<br />

Report Focus: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

- By Type- (Independent pharmacy, Chain)<br />

- By Region (North America, Europe, Asia Pacific, Rest of World)<br />

- By Country (US, Canda, UK, Germany, China, India, Japan)<br />

- By Company (Walgreen Bots Alliance, CVS Health, Rite Aid, Jean Coutu, Nepstar , Albertsons,<br />

Rossamann, Nepstar ).<br />

19


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Rapidly growing demand for pharmaceutical drugs has been boosting the market of pharmaceutical<br />

retail on a global level.<br />

Figure 1: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

2013 2014 2015 2016 2017<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

20


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Surging health consciousness amongst consumers as well as escalating e-commerce industry is likely to<br />

drive the demand growth in forecast period.<br />

Figure 2: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023 (USD Billion)<br />

CAGR 2018-2023<br />

xx%<br />

2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

21


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>- By Distribution Channel<br />

Offline pharmaceutical retail channel held the major market share of approximately 95.54%, by<br />

value, in the year 2017.<br />

Figure 14: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By<br />

Product Type, 2017 (%)<br />

Key Drivers<br />

xx<br />

Online<br />

Offline<br />

xx<br />

Source: Azoth Analytics Estimates<br />

xx<br />

22


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>- By Distribution Channel<br />

In the forecast period, Offline channel is likely to maintain it’s dominant position in the overall market.<br />

However, online channel is anticipated to be the faster growing segment.<br />

Figure 15: <strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By<br />

Product Type, 2023 (%)<br />

Key Drivers<br />

xx<br />

Online<br />

Offline<br />

xx<br />

Source: Azoth Analytics Estimates<br />

xx<br />

23


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong><br />

<strong>Global</strong> Online <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Replacement Devices <strong>Market</strong>, By Value<br />

Figure 16: <strong>Global</strong> Online <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By<br />

Value, 2013-2017 (USD Billion)<br />

Figure 17: <strong>Global</strong> Online <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By<br />

Value, Forecast, 2018-2023(USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

CAGR 2018-2023<br />

xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

24


<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong><br />

<strong>Global</strong> Offline <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Replacement Devices <strong>Market</strong>, By Value<br />

Figure 18: <strong>Global</strong> Offline <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> ,<br />

By Value, 2013-2017 (USD Billion)<br />

Figure 19: <strong>Global</strong> Offline <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>,<br />

By Value, Forecast, 2018-2023(USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

CAGR 2018-2023<br />

xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

25


<strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong><br />

Figure 22: <strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong><br />

<strong>Retail</strong> <strong>Market</strong> , By Value, 2013-2017 (USD Billion)<br />

Figure 23: <strong>Global</strong> Independent pharmacy <strong>Pharmaceutical</strong><br />

<strong>Retail</strong> <strong>Market</strong>,By Value, Forecast, 2018-2023(USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

CAGR 2018-2023<br />

xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

26


<strong>Global</strong> Organized Chain <strong>Pharmaceutical</strong> <strong>Market</strong><br />

<strong>Global</strong> <strong>Pharmaceutical</strong> <strong>Retail</strong><br />

Replacement Devices <strong>Market</strong>, By Value<br />

Figure 24: <strong>Global</strong> Organized Chain <strong>Pharmaceutical</strong> <strong>Market</strong>,<br />

By Value, 2013-2017 (USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

Figure 25: <strong>Global</strong> Organized Chain <strong>Pharmaceutical</strong> <strong>Market</strong>,<br />

By Value, Forecast, 2018-2023(USD Billion)<br />

CAGR 2018-2023<br />

xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

27


North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Overview<br />

Increasing penetration addition to increasing prevalence of chronic ailments have been backing the North<br />

America pharmaceutical <strong>Retail</strong> market.<br />

Figure 30: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2017 (USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

Source: Azoth Analytics Estimates<br />

2013 2014 2015 2016 2017<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

28


North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Overview<br />

Noteworthy growth in the regional market is attributed to high focus on international sales, mergers and<br />

acquisitions.<br />

Figure 31: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, Forecast, 2018-2023 (USD Billion)<br />

CAGR 2018-2023<br />

xx%<br />

2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

Xx<br />

29


North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Product Type<br />

Figure 43: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2013-2023 (USD Billion)<br />

CAGR 2013-2017<br />

Independent : xx%<br />

Chain : xx%<br />

Others : xx%<br />

2013 2014 2015 2016 2017<br />

Independent pharmacy Chain Others<br />

2013 2014 2015 2016 2017<br />

Independent pharmacy xx xx xx xx xx<br />

Chain xx xx xx xx xx<br />

Others xx xx xx xx xx<br />

Source: Azoth Analytics Estimates<br />

30


North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Product Type<br />

Figure 44: North America <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2018-2023 (USD Billion)<br />

CAGR 2018-2023<br />

Independent : xx%<br />

Chain : xx%<br />

Others : xx%<br />

2018 2019 2020 2021 2022 2023<br />

independent Chain Others<br />

2013 2014 2015 2016 2017<br />

Independent pharmacy xx xx xx xx xx<br />

Chain xx xx xx xx xx<br />

Others xx xx xx xx xx<br />

Source: Azoth Analytics Estimates<br />

31


U.S. <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Value<br />

United States pharmaceutical retail market has increasingly grown through healthy growth in<br />

pharmaceutical drugs industry in the country.<br />

Figure 45: U.S. <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong> Size, By Value, 2013-2023 (USD Billion)<br />

CAGR 2013-2017<br />

xx%<br />

CAGR 2018-2023<br />

xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Source: Azoth Analytics Estimates<br />

Xx<br />

Xx<br />

• .<br />

Xx<br />

Xx<br />

Xx<br />

32


U.S <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>, By Type<br />

Figure 64: U.S <strong>Pharmaceutical</strong> <strong>Retail</strong> <strong>Market</strong>: By Product Type, By Value, 2013-2023 (USD Billion)<br />

CAGR 2013-2017<br />

Independent : xx%<br />

Chain : xx%<br />

Others : xx%<br />

CAGR 2018-2023<br />

Independent : xx%<br />

Chain : xx%<br />

Others: xx%<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Independent Chain Others<br />

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br />

Independen<br />

t pharmacy<br />

xx xx xx xx xx xx xx xx xx xx xx<br />

Chain xx xx xx xx xx xx xx xx xx xx xx<br />

Others xx xx xx xx xx xx xx xx xx xx xx<br />

Source: Azoth Analytics Estimates<br />

33


About Azoth Analytics Pvt Ltd.<br />

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy<br />

services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &<br />

beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic<br />

market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).<br />

Related Reports:<br />

<strong>Global</strong> <strong>Pharmaceutical</strong> Packaging Equipment <strong>Market</strong> – By Product Type (Solids, Semi-Solids, Liquids), By Package Type (Primary,<br />

Secondary, Labeling and Serialization), By Region, By Country: Opportunities and Forecasts (2018-2023)<br />

<strong>Global</strong> <strong>Pharmaceutical</strong> Plastic Packaging <strong>Market</strong> - By Type, By Drug Delivery, By Polymer Type, By Packaging Type, By Region, By Country:<br />

Opportunities and Forecast (2017-2022) -– By Type (Rigid & Packaging), By Packaging Type (Plastic Bottles, Blister Pack, Caps & Closures,<br />

Prefilled Syringe, Others), By Drug Delivery (Oral, Parenteral, Inhalation, Transdermal), By Polymer (Polypropylene, PVC, HDPE, LDPE,<br />

Polyester, Polystyrene, Others)<br />

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for<br />

any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis<br />

provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.<br />

220

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!